AMG National Trust Bank Purchases 1,152 Shares of Colgate-Palmolive Company $CL

AMG National Trust Bank increased its position in shares of Colgate-Palmolive Company (NYSE:CL) by 12.2% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 10,578 shares of the company’s stock after acquiring an additional 1,152 shares during the period. AMG National Trust Bank’s holdings in Colgate-Palmolive were worth $962,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in CL. Brighton Jones LLC grew its position in shares of Colgate-Palmolive by 4.4% in the 4th quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock valued at $962,000 after buying an additional 450 shares during the last quarter. Avantax Planning Partners Inc. grew its position in shares of Colgate-Palmolive by 7.5% in the 1st quarter. Avantax Planning Partners Inc. now owns 5,407 shares of the company’s stock valued at $507,000 after buying an additional 378 shares during the last quarter. Harel Insurance Investments & Financial Services Ltd. bought a new stake in shares of Colgate-Palmolive in the 1st quarter valued at about $37,000. Catalyst Capital Advisors LLC grew its position in shares of Colgate-Palmolive by 45.2% in the 1st quarter. Catalyst Capital Advisors LLC now owns 1,580 shares of the company’s stock valued at $148,000 after buying an additional 492 shares during the last quarter. Finally, Brookstone Capital Management grew its position in shares of Colgate-Palmolive by 508.8% in the 1st quarter. Brookstone Capital Management now owns 118,439 shares of the company’s stock valued at $11,098,000 after buying an additional 98,984 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Up 0.8%

Shares of NYSE:CL opened at $77.10 on Friday. The company has a market capitalization of $62.32 billion, a price-to-earnings ratio of 21.66, a P/E/G ratio of 4.44 and a beta of 0.34. The company has a debt-to-equity ratio of 6.79, a current ratio of 0.89 and a quick ratio of 0.57. The business’s 50-day moving average is $80.45 and its 200-day moving average is $86.33. Colgate-Palmolive Company has a 1 year low of $74.62 and a 1 year high of $100.18.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, October 31st. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.89 by $0.02. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The business had revenue of $5.13 billion for the quarter, compared to the consensus estimate of $5.17 billion. During the same period in the prior year, the business earned $0.91 EPS. The firm’s revenue for the quarter was up 1.9% on a year-over-year basis. Equities research analysts predict that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 17th will be paid a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a yield of 2.7%. The ex-dividend date of this dividend is Friday, October 17th. Colgate-Palmolive’s dividend payout ratio is 58.43%.

Analysts Set New Price Targets

A number of research firms have commented on CL. UBS Group reduced their price target on Colgate-Palmolive from $99.00 to $92.00 and set a “buy” rating on the stock in a research report on Wednesday, October 8th. Raymond James Financial reduced their price target on Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating on the stock in a research report on Monday, October 20th. Deutsche Bank Aktiengesellschaft set a $86.00 price objective on Colgate-Palmolive in a research note on Friday, October 10th. Bank of America dropped their price objective on Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating on the stock in a research note on Wednesday, October 8th. Finally, Morgan Stanley dropped their price objective on Colgate-Palmolive from $104.00 to $96.00 and set an “overweight” rating on the stock in a research note on Monday, August 4th. Eight analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $91.50.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.